Citigroup’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$139K Sell
37,951
-33,766
-47% -$124K ﹤0.01% 3529
2025
Q1
$310K Buy
71,717
+12,737
+22% +$55K ﹤0.01% 3183
2024
Q4
$189K Buy
58,980
+4,396
+8% +$14.1K ﹤0.01% 3622
2024
Q3
$156K Buy
54,584
+36,707
+205% +$105K ﹤0.01% 3759
2024
Q2
$50.1K Buy
17,877
+2,157
+14% +$6.04K ﹤0.01% 3846
2024
Q1
$44.6K Buy
15,720
+4,086
+35% +$11.6K ﹤0.01% 3944
2023
Q4
$47.6K Buy
11,634
+11,026
+1,813% +$45.1K ﹤0.01% 3802
2023
Q3
$1.93K Sell
608
-20,330
-97% -$64.7K ﹤0.01% 4213
2023
Q2
$69.5K Buy
20,938
+18,707
+839% +$62.1K ﹤0.01% 3768
2023
Q1
$4.75K Sell
2,231
-40,943
-95% -$87.2K ﹤0.01% 4262
2022
Q4
$116K Buy
43,174
+9,022
+26% +$24.3K ﹤0.01% 3282
2022
Q3
$111K Sell
34,152
-219,589
-87% -$714K ﹤0.01% 3339
2022
Q2
$1.24M Buy
253,741
+163,787
+182% +$799K ﹤0.01% 1910
2022
Q1
$686K Sell
89,954
-235,371
-72% -$1.79M ﹤0.01% 2640
2021
Q4
$3.01M Buy
325,325
+200,959
+162% +$1.86M ﹤0.01% 1654
2021
Q3
$1.77M Sell
124,366
-160,744
-56% -$2.29M ﹤0.01% 1989
2021
Q2
$4.74M Buy
285,110
+283,491
+17,510% +$4.71M ﹤0.01% 1456
2021
Q1
$29K Sell
1,619
-2,557
-61% -$45.8K ﹤0.01% 4365
2020
Q4
$31K Buy
4,176
+3,204
+330% +$23.8K ﹤0.01% 4384
2020
Q3
$4K Sell
972
-1,660
-63% -$6.83K ﹤0.01% 4770
2020
Q2
$10K Sell
2,632
-240
-8% -$912 ﹤0.01% 4638
2020
Q1
$9K Buy
2,872
+680
+31% +$2.13K ﹤0.01% 4657
2019
Q4
$11K Buy
2,192
+1,670
+320% +$8.38K ﹤0.01% 4690
2019
Q3
$4K Sell
522
-2,430
-82% -$18.6K ﹤0.01% 4843
2019
Q2
$22K Sell
2,952
-2,527
-46% -$18.8K ﹤0.01% 4541
2019
Q1
$41K Buy
+5,479
New +$41K ﹤0.01% 4145